选择４６例按ＷＨＯ标准确诊的Ⅱ型糖尿病人，无肝肾功能异常及严重并发症，在饮食控制及其它口服降糖药治疗同时，加服拜唐苹（５０～１００ｍｇ／次，每日３次）４周，观察其空腹及餐后２ｈ血糖变化，并以３２例病程、年龄相仿，单纯给饮食控制及其它口服降糖药治疗的Ⅱ型糖尿病人作对照。结果发现加拜唐苹治疗组与对照组在治疗前，空腹血糖及餐后２ｈ血糖分别为９８±０９５、９２±０９７和１３２７±０６２、１２８７±０７３，差异无显著性（Ｐ＞００５），治疗４周后，加拜唐苹治疗组与对照组空腹血糖分别为６８±０３６、７１±０８３，两组差异无显著性（Ｐ＞０５），但餐后２ｈ血糖分别为８３±０８２、１１６８±０９３，差异有高度显著性（Ｐ＜０００１），与治疗前比较，加拜唐苹治疗组餐后２ｈ血糖下降３７５％，而对照组仅下降９２％。认为拜唐苹在饮食控制条件下，与其它口服降糖药合用，可明显降低餐后２ｈ血糖 Choose 46 cases of type II diabetes diagnosed according to WHO standards, no liver and kidney dysfunction and serious complications, diet control and other oral hypoglycemic agents at the same time, plus pay worship Tang Ping (50 ~ 100mg / time 3 Times) for 4 weeks. The changes of fasting blood glucose and 2h postprandial blood glucose were observed. Patients with type 2 diabetes mellitus treated with diet control and other oral hypoglycemic agents were given 32 cases of similar duration of illness. The results showed that fasting blood glucose and 2h postprandial blood glucose were up to 9.88 ± 0.95, 92 ± 0.97 and 1327 ± 0.62, 12 87 ± 073, no significant difference (P> 005). After 4 weeks of treatment, the fasting blood glucose of Jiabituotan group and control group were respectively 68 ± 036, 71 ± 0 83, there was no significant difference between the two groups (P> 05), but the postprandial blood glucose at 2h was 83 ± 082 and 1168 ± 093, respectively, the difference was highly significant (P <0001 ). Compared with the pretreatment, the blood sugar at 37h postprandial blood glucose was reduced by 37.5% in the Jiabangtangping treatment group, but only decreased by 9.2% in the control group. Believed that Tang Tang Ping in the diet control conditions, combined with other oral hypoglycemic agents, can significantly reduce the 2h postprandial blood glucose